Abstract: A method of controlling injection of a drug includes receiving a captured medical image of an object, identifying an object of interest from the medical image, based on a position and a shape of the object of interest, determining a drug injection position, based on the position and the shape of the object of interest, determining a plurality of electrode insertion positions, the plurality of electrodes being configured to supply a current to move the drug, defining a drug movement path based on a shape of the identified object of interest, generating current sequence information to move the drug along the drug movement path, the current sequence information defining a current applied over time to each of the plurality of electrodes, and outputting the current sequence information to a current source apparatus.

Abstract: A transparent display device comprises: a first substrate including a display area and first to fourth bezel areas surrounding the display area, wherein the display area includes a plurality of pixel regions each including an emitting portion and a transparent portion; a second substrate facing the first substrate; a transparent dam between the first and second substrates and in the first to fourth bezel areas; a first pad electrode on the first substrate and in the first bezel area; and a first color filter pattern on the second substrate and in the first bezel area.

Abstract: A substrate processing method is provided. The substrate processing method comprises loading a substrate onto a substrate support inside a chamber, forming a plasma inside the chamber, providing a first DC pulse signal to an electromagnet that generates a magnetic field inside the chamber and processing the substrate with the plasma, wherein the first DC pulse signal is repeated at a first period including a first section and a second section subsequent to the first section, the first DC pulse signal has a first level during the first section, and the first DC pulse signal has a second level different from the first level during the second section.

Abstract: The present invention relates to a fusion protein comprising a SARS-CoV-2-derived receptor-binding domain and a nucleocapsid protein, and the use thereof. The fusion protein comprising a coronavirus-derived receptor-binding domain and a nucleocapsid protein is highly applicable to a multivalent vaccine composition having greatly improved in-vivo half-life and remarkably superior efficacy compared to an immunogenic composition comprising only a receptor-binding domain. In particular, the fusion protein can greatly improve the titer of the coronavirus-specific antibody formation and T-cell immune response, and is thus useful for the prevention and treatment of coronaviruses comprising SARS-CoV-2.

Abstract: A gravity type water-purifying device is provided.

Abstract: Proposed is a road slope estimation method for a vehicle. The method includes: calculating, by a controller, a basic slope based on an output value of an acceleration sensor of the vehicle; calculating, by the controller, an acceleration/deceleration correction value from an acceleration/deceleration correction map; and calculating, by the controller, a turning correction value from a turning correction map. The method further includes: calculating, by the controller, a final slope based on the basic slope, the acceleration/deceleration correction value, and the turning correction value; and controlling the vehicle based on the final slope.

Abstract: The stable pharmaceutical formulation according to the present disclosure comprises (A) an antibody or antigen-binding fragment thereof that binds to an interleukin-6 receptor; (B) a surfactant; (C) stabilizers; and (D) a buffer. The stable pharmaceutical formulation according to the present disclosure has a low viscosity even when it contains an antibody, especially at a high concentration, and has excellent long-term storage stability based on excellent stability under accelerated and severe conditions, and may be administered intravenously or subcutaneously.

Abstract: A stable pharmaceutical formulation according to the present disclosure contains: a recombinant fusion protein; a surfactant; a sugar or a derivative thereof; a buffer; and an isotonic agent. The stable pharmaceutical formulation according to the present disclosure has low viscosity while containing the recombinant fusion protein, may maintain excellent stability under long-term storage conditions, accelerated conditions and stress conditions, and may be administered intraocularly.

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: An inner shroud block component for a gas turbine. The inner shroud block has a radially inward facing surface with an abradable material applied thereto. The abradable material includes a zone of ridges that extend radially inwardly from the radially inward facing surface to minimize the clearance between the inner shroud block and the blade tip of a turbine blade. The abradable material may be ceramic and may be abraded by the blade tip if contact occurs between the blade tip and the inner shroud block. The zone of ridges extend along the radially inward facing surface in parallel to a direction of rotation of the turbine blade.

Abstract: A turbine blade for a gas turbine engine. The turbine blade includes an airfoil having a tip cavity. The tip cavity has a floor bounded by a wall. A pocket opening is formed in the wall proximate a trailing edge of the turbine blade. A passageway communicates cooling medium from an internal cooling circuit to a cooling hole formed in part through the floor and in part through the trailing edge.

Abstract: A turbine blade for a gas turbine engine. The turbine blade includes an airfoil having a tip cavity. The tip cavity has a floor bounded by a wall. A pocket opening is formed in the wall proximate a trailing edge of the turbine blade. A passageway communicates cooling medium from an internal cooling circuit to a cooling hole formed in part through the floor and in part through the trailing edge.

Abstract: An inner shroud block component for a gas turbine. The inner shroud block has a radially inward facing surface with an abradable material applied thereto. The abradable material includes a zone of ridges that extend radially inwardly from the radially inward facing surface to minimize the clearance between the inner shroud block and the blade tip of a turbine blade. The abradable material may be ceramic and may be abraded by the blade tip if contact occurs between the blade tip and the inner shroud block. The zone of ridges extend along the radially inward facing surface in parallel to a direction of rotation of the turbine blade.

Abstract: An inner shroud block component for a gas turbine. The inner shroud block has a surface with a plurality of wells formed therein. An array of protuberances extend away from a base surface of each of the wells. The array of protuberances produces convective cooling of the inner shroud block, resulting in increased cooling of the inner shroud block and better part life. The increased cooling capacity also allows the turbine to operate at higher temperatures, which results in additional power generation.

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: A gas turbine includes a housing in which combustion gas flows; a rotor section rotatably installed in the housing; and a turbine blade configured to rotate the rotor section by receiving a rotational force from the combustion gas and to be cooled by a cooling fluid flowing in a cooling path, the turbine blade including a tip side provided with tip cooling holes through which a portion of the cooling fluid in the cooling path is discharged from the turbine blade. The tip cooling holes include a first tip cooling hole formed in a pressure surface of the turbine blade, and a second tip cooling hole formed in a suction surface of the turbine blade. The gas turbine can easily maintain a gap between the tip side of the turbine blade and an inner circumferential surface of the housing, preventing degradation of the turbine blade efficiency.

Abstract: The present disclosure provides a surface-modified alginate micro-capsule having a core-shell structure in which a core is fluidizable phase alginate, and a shell is alginate hydrogel crosslinked with epigallocatechin gallate dimer, a preparation method thereof, and a cell encapsulation method using the same.

Abstract: A gas turbine includes a housing in which combustion gas flows; a rotor section rotatably installed in the housing; and a turbine blade configured to rotate the rotor section by receiving a rotational force from the combustion gas and to be cooled by a cooling fluid flowing in a cooling path, the turbine blade including a tip side provided with tip cooling holes through which a portion of the cooling fluid in the cooling path is discharged from the turbine blade. The tip cooling holes include a first tip cooling hole formed in a pressure surface of the turbine blade, and a second tip cooling hole formed in a suction surface of the turbine blade. The gas turbine can easily maintain a gap between the tip side of the turbine blade and an inner circumferential surface of the housing, preventing degradation of the turbine blade efficiency.

Abstract: The present invention relates to a film bulk acoustic wave device and a method of manufacturing the same, wherein comprising an acoustic reflective layer which is formed on a substrate by removing a sacrificial layer on the substrate and becomes an empty space; an oxidation protective film or etch protecting film which is formed in a pattern that divides a resonance region to form the acoustic reflective layer on the sacrificial layer; a thermal oxidation film which is formed by partially thermally oxidizing the sacrificial layer in an electrode region where the oxidation protective film or the etch protecting film is not formed; and a lower electrode, a piezoelectric thin film, and an upper electrode all of which are disposed on the thermal oxide. Further, the present invention is directed to a method of manufacturing the same.

Abstract: The present invention relates to a film bulk acoustic wave device and a method of manufacturing the same, wherein comprising an acoustic reflective layer which is formed on a substrate by removing a sacrificial layer on the substrate and becomes an empty space; an oxidation protective film or etch protecting film which is formed in a pattern that divides a resonance region to form the acoustic reflective layer on the sacrificial layer; a thermal oxidation film which is formed by partially thermally oxidizing the sacrificial layer in an electrode region where the oxidation protective film or the etch protecting film is not formed; and a lower electrode, a piezoelectric thin film, and an upper electrode all of which are disposed on the thermal oxide.